Lipid oxidation products and oxidized low-density lipoproteins impair platelet-derived growth factor receptor activity in smooth muscle cells: Implication in atherosclerosis

33Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The platelet-derived growth factor receptor-beta (PDGFRβ) signaling pathway regulates smooth muscle cell (SMC) migration and proliferation in the vascular wall. Oxidized low-density lipoproteins; (oxLDLs) and 4-hydroxynonenal (4-HNE) induce a dual effect on PDGFRβ signaling. Short-term incubation of SMCs with oxLDLs and 4-HNE induced PDGFRβ activation. Long-term incubation triggered a desensitization of PDGFR to its own agonist, with a progressive inhibition of PDGFRβ phosphorylation, associated with increased formation of HNE-PDGFR adducts in SMC and in vivo, in the aortae of apoE-deficient mice. Hydralazine used as carbonyl scavenger prevented PDGFRβ inhibition in vitro and in vivo. In conclusion, PDGFRβ is a target for 4-HNE, acrolein and oxidative stress and its progressive inhibition may contribute to defective SMC proliferation and decrease the stability of a vulnerable plaque. © W. S. Maney & Son Ltd.

Cite

CITATION STYLE

APA

Vindis, C., Escargueil-Blanc, I., Uchida, K., Elbaz, M., Salvayre, R., & Negre-Salvayre, A. (2007). Lipid oxidation products and oxidized low-density lipoproteins impair platelet-derived growth factor receptor activity in smooth muscle cells: Implication in atherosclerosis. In Redox Report (Vol. 12, pp. 96–100). https://doi.org/10.1179/135100007X162248

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free